Skip to main content

Oncology Startups

Updated October 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 311 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
311
Total Funding
$1.4B
Avg Funding
$57.2M
Global Reach
8
countries

Top Cities for Oncology

Cambridge
Palo Alto
Boston
San Diego
London
Copenhagen

Recently Funded Companies

Export
Cambridge, United Kingdom

Treating the seeds of cancer

$949K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.

$62.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

$225.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

$66.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

$16.3M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.

$1.5M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Berkeley, United States

KuriBio builds a nanotechnology platform for therapeutic applications in oncology and beyond.

$150K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Sydney, Australia

Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.

$7.4M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.

Sep 2023

Founder Contacts

41,000+ verified contacts

Nijmegen, The Netherlands

Pleco Therapeutics is a pharmaceutical manufacturing company that provides pre-clinical development programs for cancer treatment.

$17.2M raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Boston, United States

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

$175.0M raised
Sep 2024

Founder Contacts

41,000+ verified contacts

Boston, United States

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

$110.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Dallas, United States

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

$4.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Epigene Labs designs genomics-driven drug for precision oncology.

$1.6M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

$39.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Wilmette, United States

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

$135.0M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Nashville, United States

Thyme Care provides value-based oncology management services designed to coordinate care for individuals diagnosed with cancer.

$125.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Hünenberg, Switzerland

CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.

$117K raised
Sep 2024

Founder Contacts

41,000+ verified contacts

San Carlos, United States

ZAP Surgical Systems is a medical company that designs and manufactures a radiosurgery platform for treating brain tumors.

$11.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Tucson, United States

Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.

$265K raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Raleigh, United States

Gradient Medical develops novel interventional oncology services to bring ACE therapy to the clinic.

$75K raised
Sep 2022

Founder Contacts

41,000+ verified contacts

Ingatestone, United Kingdom

Big Picture Bio is a developer of an AI-driven platform designed to identify, design, and optimize cancer combination therapies.

$2.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Hong Kong, Hong Kong

Connexus Therapeutics is a private, venture-backed biotechnology startup.

$5.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Bantam Pharmaceutical has deep experience in oncology drug discovery and development including R&D and partnering.

$25.0M raised
Sep 2021

Founder Contacts

41,000+ verified contacts

Carlsbad, United States

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

$400.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 311 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 311 oncology companies tracked in the VCBacked database.

Average Funding
$57.2M
Total Funding Tracked
$1.4B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.Boston
4 companies$535.0M
2.Copenhagen
2 companies$1.5M
3.Cambridge
1 companies$949K
4.Palo Alto
1 companies$62.5M
5.San Diego
1 companies$66.0M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked